Literature DB >> 29532755

Homocysteine and Hyperhomocysteinaemia.

Bozidarka L Zaric1, Milan Obradovic1, Vladan Bajic1, Mohamed A Haidara2, Milos Jovanovic3, Esma R Isenovic1.   

Abstract

Homocysteine (Hcy) is a thiol group containing the amino acid, which naturally occurs in all humans. Hcy is degraded in the body through two metabolic pathways, while a minor part is excreted through kidneys. The chemical reactions that are necessary for degradation of Hcy require the presence of folic acid, vitamins B6 and B12. Consequently, the level of the total Hcy in the serum is influenced by the presence or absence of these vitamins. An elevated level of the Hcy, hyperhomocysteinemia (HHcy) and homocystinuria is connected with occlusive artery disease, especially in the brain, the heart, and the kidney, in addition to venous thrombosis, chronic renal failure, megaloblastic anemia, osteoporosis, depression, Alzheimer's disease, pregnancy problems, and others. Elevated Hcy levels are connected with various pathologies both in adult and child population. Causes of HHcy include genetic mutations and enzyme deficiencies in 5, 10-methylenetetrahydrofolate reductase (MTHFR) methionine synthase (MS), and cystathionine β-synthase (CβS). HHcy can be caused by deficiencies in the folate, vitamin B12 and to a lesser extent, deficiency in B6 vitamin what influences methionine metabolism. Additionally, HHcy can be caused by the rich diet and renal impairment. This review presents literature data from recent research related to Hcy metabolism and the etiology of the Hcy blood level disorder. In addition, we also described various pathological mechanisms induced by hereditary disturbances or nutritional influences and their association with HHcy induced pathology in adults and children and treatment of these metabolic disorders. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Homocysteine; cardiovascular diseases; disturbance of homocysteine metabolism; homocysteine metabolism; hyperhomocysteinemia; nutritional deficiencies.

Mesh:

Substances:

Year:  2019        PMID: 29532755     DOI: 10.2174/0929867325666180313105949

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  42 in total

1.  L-cysteine/cystathionine-β-synthase-induced relaxation in mouse aorta involves a L-serine/sphingosine-1-phosphate/NO pathway.

Authors:  Emma Mitidieri; Danila Gurgone; Elisabetta Caiazzo; Teresa Tramontano; Carla Cicala; Raffaella Sorrentino; Roberta d'Emmanuele di Villa Bianca
Journal:  Br J Pharmacol       Date:  2019-04-22       Impact factor: 8.739

Review 2.  Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.

Authors:  Karim Zuhra; Fiona Augsburger; Tomas Majtan; Csaba Szabo
Journal:  Biomolecules       Date:  2020-04-30

3.  Hyperhomocysteinemia is a risk factor for postoperative ischemia in adult patients with moyamoya disease.

Authors:  Junsheng Li; Peicong Ge; Qian Zhang; Fa Lin; Rong Wang; Yan Zhang; Dong Zhang; Wen Wang; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2021-01-27       Impact factor: 3.042

4.  Resveratrol: A new approach to ameliorate hyperhomocysteinaemia-induced renal dysfunction.

Authors:  Xuan Zhao; Qing-Chen Hui; Rui Xu; Ning Gao; Ping Cao
Journal:  Exp Ther Med       Date:  2022-06-10       Impact factor: 2.751

5.  Juvenile patients with the homozygous MTHFR C677T genotype develop ischemic stroke 5 years earlier than wild type.

Authors:  Paul R J Ames; Giovanna D'Andrea; Vincenzo Marottoli; Alessia Arcaro; Luigi Iannaccone; Fabrizio Gentile; Maurizio Maraglione
Journal:  J Thromb Thrombolysis       Date:  2022-08-02       Impact factor: 5.221

6.  Liver Cirrhosis Patients Homozygous for MTHFR C677T Develop Portal Vein Thrombosis 8 Years Earlier Than Wild Type.

Authors:  Paul R J Ames; Giovanna D'Andrea; Alessia Arcaro; Vincenzo Marottoli; Luigi Iannaccone; Maurizio Maraglione; Fabrizio Gentile
Journal:  Dig Dis Sci       Date:  2022-08-24       Impact factor: 3.487

Review 7.  Transsulfuration, minor player or crucial for cysteine homeostasis in cancer.

Authors:  Hai-Feng Zhang; Ramon I Klein Geltink; Seth J Parker; Poul H Sorensen
Journal:  Trends Cell Biol       Date:  2022-03-29       Impact factor: 21.167

Review 8.  Inherited metabolic diseases mimicking hereditary spastic paraplegia (HSP): a chance for treatment.

Authors:  Hélio A G Teive; Carlos Henrique F Camargo; Eduardo R Pereira; Léo Coutinho; Renato P Munhoz
Journal:  Neurogenetics       Date:  2022-04-09       Impact factor: 3.017

9.  Controversial Role of Folic Acid on Diabetic Auditory Neuropathy.

Authors:  Aida Doostkam; Hossein Mirkhani; Kamyar Iravani; Saied Karbalay-Doust; Afsaneh Doosti; Elham Nadimi; Fatema Pirsalami
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-28

10.  Homocysteine fibrillar assemblies display cross-talk with Alzheimer's disease β-amyloid polypeptide.

Authors:  Dorin Sade Yazdi; Dana Laor Bar-Yosef; Hanaa Adsi; Topaz Kreiser; Shahaf Sigal; Santu Bera; Dor Zaguri; Shira Shaham-Niv; Damilola S Oluwatoba; Davide Levy; Myra Gartner; Thanh D Do; Dan Frenkel; Ehud Gazit
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.